Swedish pharmaceutical and medtech centre to boost R&D (research and development):
This article was originally published in Clinica
Executive Summary
A new centre established at the University of Lund, and the first of its kind in Sweden, is set to promote research into medical devices and pharmaceuticals. Known as the "medicines centre", its aim is to make research more transparent and to increase the cross-disciplinary exchange of information in fields such as molecular biology and cell biology. It is hoped that the centre will develop new technologies and methods that will be of direct interest to both national and international industry. The centre will not be concerned with legal or patent matters with respect to its research, as this will be handled by Lund University's innovations unit, which was set up in 2003. Instead, it will urge more co-operations between researchers, industry and research financing bodies.
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.